Overview / Abstract: |
Depression is one of the leading causes of disability worldwide. It affects individuals, families, businesses, and society and is common in patients seeking care in the primary care setting. Approximately 55% of patients will respond to treatment with the initial antidepressant. Yet, even in those patients who respond to treatment and achieve remission, residual symptoms can significantly inhibit functionality and increase the risk of relapse and recurrence. Despite these challenges, MDD can be effectively managed, particularly when the clinician and patient mutually define what remission means to the patient and work together towards achieving sustained remission. This archive of a CME Outfitters symposium on MDD features expert faculty offering new perspectives on treating this pervasive disorder, highlights residual symptoms as a challenge to clinicians, and ways to engage with patients to optimize management of all symptoms. |
Expiration |
Jun 16, 2018 |
Discipline(s) |
Athletic Trainer , Counselor CE, Nurse Practitioner , Nursing CNE, Occupational Therapy CE, Pharmacy CPE, Physical Therapy CE, Physician CME, Physician Assistant CME, Psychology CE, Social Work CE |
Format |
Online, Performance Improvement, Podcast, Webinar / Webcast / Video |
Credits / Hours |
2.0 |
Accreditation |
APA, AANP, AAPA |
Presenters / Authors / Faculty |
Roger S. McIntyre, MD, FRCPC (Moderator) Catherine Judd, MS, PA-C, CAQ-Psy, DFAAPA Gregory W. Mattingly, MD |
Sponsors / Supporters / Grant Providers |
Takeda Pharmaceuticals U.S.A., Inc.; Lundbeck |
Keywords / Search Terms |
CME Outfitters, LLC MDD, depression, major depressive disorder, psychiatry, psychiatric, psychiatrist, psych, mental health, mental illness, bipolar Free CE CME |